Startups
StemSight is a cell therapy startup developing novel treatments for blindness operating in Tampere, Finland. StemSight’s off-the-shelf cell therapy product could provide patients with a cure to regain their vision. StemSight is the first human stem cell startup from Finland to receive funding, announcing a € seed round from Voima Ventures. StemSight has been selected among the 14 European Biotech startups selected to compete in the semifinals of EIT Health’s Catapult programme and has won the New Nordics Pitch Competition Finland 2022.
Overview
Location
Finland, West Finland, Tampere
Employees
11-50
Total raised
$2.41M
Founded date
2021
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 7
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Mar 6, 2026 | Germany’s Cellbox Solutions raises €3.5 million to expand global transport technology for living cells | Cellbox Solutions, a Cologne-based warm-chain logistics technology company enabling the global transport of living cells under controlled physiological conditions, has raised €3.5 million in a Series A financing – which remains open for oth... |
| Feb 17, 2025 | Bioretec and StemSight: Pioneering Hope in Medical Innovation | In the realm of medical innovation, two Finnish companies are making waves. Bioretec Ltd and StemSight are not just pushing boundaries; they are redefining the landscape of healthcare. Their recent achievements signal a bright future for pa... |
| Feb 13, 2025 | The gift of sight – BioTech startup StemSight raises €2.3 million to tackle severe blindness | StemSight, a Tampere-based BioTech startup developing stem cell therapies for vision restoration, has raised €2.3 million in funding to advance StemSight toward clinical trials for limbal stem cell deficiency (LSCD), a specific type of corn... |
| Jun 10, 2022 | 42 start-ups through to Catapult 2022-23 semifinals | We are excited to today announce the 42 promising start-ups that will go through to the semifinals of EIT Health Catapult 2022-23. Each year, the competition showcases Europe’s most promising biotech, medtech and digital health start-ups to... |
| Sep 15, 2021 | Finland’s StemSight, first human stem cell startup from Finland, announces seed funding round | All female founded StemSight is the first human stem cell startup from Finland to receive funding, announcing a €500000 seed round from Voima Ventures. Stemsight aims to help over 12 million people suffer from corneal blindness regain thei... |
| StemSight | “StemSight is a Finnish high-tech startup developing cell therapies for corneal blindness using human pluripotent stem cells.” |
Reviews 0
FAQ about StemSight Oy
When was StemSight Oy founded?
StemSight Oy was founded in 2021.
How much funding has StemSight Oy raised?
StemSight Oy has raised $2.41M in total across 1 funding round.
What has the press written about StemSight Oy?
Parsers VC has collected 7 articles mentioning StemSight Oy, among them “Germany’s Cellbox Solutions raises €3.5 million to expand global transport technology for living cells” (Mar 6, 2026) and “Bioretec and StemSight: Pioneering Hope in Medical Innovation” (Feb 17, 2025).
Is StemSight Oy still active?
Yes, StemSight Oy is active; its latest activity on Parsers VC dates from Mar 6, 2026.